Preparation of whole blood derived platelet component
Keywords:
-Abstract
-
Downloads
References
Brewer DB. Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet. Br J Haematol. 2006;133:251-8.
Gazzaniga V, Ottini V. The discovery of platelets and their function. Vesalius. 2001;7:22-6.
Wright JH, Surg J. The origin and nature of the blood plates. Boston Medic. 1906;154:643-5.
Perrota PL, Anderson KC. Blood banking and transfusion medicine-Basic principles and practice. Philadelphia: Churchill Livingstone. 2003; p.181-205.
Giangrande LF Paul. The history of blood transfusion. Br J Haematol. 2000;110:758-67.
Freireich EJ. Origins of platelet transfusion therapy. Transfus Med. 2011;25:252-6.
Blajchman MA. Platelet transfusions: a historical perspective. Am Soc Hematol. 2008;1:197.
Holbro A, Infanti L, Sigle J, Buser A. Platelet transfusion: basic aspects. Swiss Med Wkly. 2013;143:1-10.
Coller BS. Historical perspective and future directions in platelet research. J Thromb Haemost. 2011;9:374-95.
Chiewsilp P. Transfusion medicine in Thailand from past to present. J Hematol Trans Med. 2019;29:71-9.
Kuter DJ. Megakaryopoiesis and thrombopoiesis. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U. Williams Hematology. 6th ed. New York: McGrawHill; 2001. p.1339-55.
Nichol JL, Hokom MM, Hornkohl A. Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemothera. J Clin Invest. 1995;95:2973-8.
Aster RH. Pooling of platelets in the spleen: Role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest. 1966;45:645-57.
Clemetson KJ. Platelets and primary haemostasis. Thromb Res. 2012;129:220-4.
Insiripong S and Suputrobon T. Platelet and platelet used. J Maharat Nakhon Ratchasima Hosp Med Bulletin. 2008;32:147-51.
Stroncek DF, Rebulla P. Transfusion medicine 2: platelet transfusions. Lancet. 2007;370:427-38.
Hardwick J. Introduction to blood transfusion technology: Blood processing. Vox Sang. 2008;3:148-76.
Council of Europe. Guide to the preparation, use and quality assurance of blood components. 18th ed. Strasbourg: Council of Europe; 2015.
American Association of Blood Banks. Technical manual. 18th ed. Bethesda, MD: American Association of Blood Banks; 2014.
National Blood Centre, Thai Red Cross Society. Standards for blood banks and transfusion services. 4th ed. Bangkok: Udomsuksa; 2015. p. 14-18.
Alakech B, Miller B, Berry TH, Ambruso DR. Coagulation profile for cryoprecipitate produced from 24-hour stored whole blood. Lab Med. 2009;40:540-3.
Prowse CV, de Korte D, Hess JR, van der Meer PF. Commercially available blood storage containers. Vox Sang. 2013;106:1-13.
Talukdar B, Chakraborty S, Hazra R, Biswas K, Bhattacharya P. Quality assessment of platelet concentrates: A comparative study using three different methods. Inter J Biomed Res. 2017;8:194-9.
Basu D, Kulkarni R. Overview of blood components and their preparation. Indian J Anaesth. 2014;58: 529-37.
Buathong D, Buakaew J, Nukfon C. Comparison of platelet concentrates prepared from platelet rich plasma-platelet concentrate and buffy coat poor-platelet concentrate on storage days 1 and 5. Songkla Med J. 2017;35:5-16
Leelarungsun T, Klomiamsira A, Kitisapkanjana S, Wittayawiwat P, Prungchaiyaphum C, Worachun N, et al. Effect of the separation time by using an automated blood separator on the hemolysis of leukocyte poor packed red cells. J Hematol Transfus Med. 2019;29:195-203.
Yazer MH, Podlosky L, Clarke G, Nahirniak SM. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion. 2004;44:10-5.
Bejrachandra S.Platelet Additive Solutions (PAS). J Hematol Transfus Med. 2016;26:175-8.
Vani R, Soumya R, Manasa K, Car H. Storage lesions in blood components. Oxid Antioxid Med Sci. 2015;4:125-32.
Pieter F, van der Meer, de Korte D. Platelet additive solutions: A review of the latest developments and their clinical implications. Transfus Med Hemother. 2018;45:98-102.
Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Klurter H, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Trans Med. 2003;101:2426-33.
World Federation of Hemophilia. The preparation of single donor cryoprecipitate. Quebec: Montreal; 2004. p. 1-5.
Raturi M, Shastry S, Raj P. Cumulative quality assessment for whole blood-derived platelets: a compliance review. Global J Transfus Med. 2017;2:38-43.
Pakpoompong T. Review of quality control of blood components. J Hematol Transfus Med. 2010;3:205-9.
Jungkapanich P, Witthayawiwat P, Kitisapkanjana S, Prungchaiyaphum C, Janthaaksorn J. Evaluation of pooled leukocyte poor platelet concentrates in platelet additive solution. J Hematol Transfus Med. 2018;28:9-16.
Osei-Bimpong A, Saleh M, Sola-Visner M, Widness J, Veng-Pedersen P. Correction for effect of cold storage on immature platelet fraction. J Clin Lab Anal. 2010;24:431-3.
Eldin KW, Teruya J. Blood components for hemostasis. Lab Med. 2012;43:237-44.
Bosly A, Muylle L, Noens L, Pietersz R, Heim D, Hubner R. Guidelines for the tranfusion of platelet. Acta Clinica Belgica. 2006;62:36-47.
Kanpai P, Kladed S, Siriboonrit U, Meesamut V, Permpikul P. Essential composition of blood products: what is different in platelet concentrate and pooled leukocyte poor platelet concentrate?. J Hematol Transfus Med. 2019;29:91-9.
Schrezenmeier H, Seifried E. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?. Vox Sanguinis. 2010;99:1-15.
Intarakomtonchai T. Platele refractoriness. J Hematol Transfus Med. 2001;11:69-71.
